세계의 생세포 캡슐화 시장 : 폴리머 유형별, 방법별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

Live Cell Encapsulation Market with COVID-19 Impact Analysis, By Polymer Type, By Method, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

US $ 3,250 ￦ 4,503,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650 ￦ 6,443,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650 ￦ 7,829,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 생세포 캡슐화 시장 규모는 2022년 2억 3,080만 달러로 2023년부터 2030년까지 3.9%의 CAGR로 확대될 것으로 예상됩니다.

생세포 캡슐화 시장 - 시장 역학

• 기술 발전과 신제품 출시가 시장 성장을 주도합니다.
• 주요 기업들의 신제품 출시와 기술 개발이 매력적인 시장 전망을 가져올 것으로 예상됩니다. 예를 들어, 바이오인엑스(BIO INX)는 2022년 11월에 생세포 캡슐화와 고해상도 바이오패브리케이션을 결합한 최초의 상용 바이오 레진인 하이드로바이오 INX N400을 발표했습니다. 이와 함께 ViaCyte는 두 가지 획기적인 재생의료 기술 플랫폼을 개발했습니다. 손상되거나 결손된 세포를 대체하여 치료할 수 있는 인간의 다양한 질병과 질환은 세포 캡슐화 및 이식 및 줄기세포 유래 세포 대체 치료를 위한 Encaptra 시스템을 통해 해결될 수 있습니다. 이는 예측 기간 동안 시장 성장의 원동력이 될 것으로 예상됩니다.

생세포 캡슐화 시장 - 세분화 분석

• 생세포 캡슐화 세계 시장은 폴리머 유형, 방법, 용도 및 지역에 따라 세분화됩니다.
• 고분자 유형에 따라 세계 생세포 캡슐화 시장은 천연과 합성으로 구분됩니다. 예측 기간 동안 천연 부문이 시장을 지배할 것으로 예상됩니다. 가장 인기 있는 캡슐화 옵션은 천연 고분자입니다. 천연 고분자로 알려진 고분자는 자연에서 유래한 것으로 생분해성, 무독성, 생체 적합성, 재생 가능성, 변화에 대한 적응성 등으로 인해 선호되고 있습니다. 박테리아, 동물, 식물 등 자연 유래이기 때문에 신체가 인식할 수 있는 특성을 보여줌으로써 세포나 조직과 상호작용할 수 있고, 그 결과 이물질로 인식되지 않습니다. 지질, 단백질, 다당류와 같은 천연 고분자는 소수성 또는 친수성 활성 성분을 고체상, 액상 또는 기체상으로 필요한 곳으로 운반 및 분배하기 위해 캡슐화로 사용되어 왔습니다. 이는 예측 기간 동안 시장 성장을 주도하고 있습니다.

생세포 캡슐화 시장 - 지리적 인사이트

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카로 나뉩니다. 이 지역은 비지니스를 가져오는 국가에 따라 더 세분화됩니다. 예측 기간 동안 북미가 시장을 지배할 것으로 보입니다. 이 시장의 확대는 주요 기업의 존재, 1인당 의료비 지출 증가, 미국과 캐나다의 R&D 프로그램에 대한 자금 지원 및 투자 증가, 의료 인프라 구축 등 여러 요인에 기인하는 것으로 보입니다. 2021년 9월에 발표된 미국제약협회(PhRMA) 보고서에 따르면, 바이오제약 기업들은 지금까지 연구개발에 1조 달러 이상을 투자했으며, 같은 기간 동안 PhRMA 회원사들은 약 910억 달러를 투자했습니다. 또한 2021년 12월 캐나다 앨버타 주 정부는 캐나다 앨버타주의 생명과학 및 제약 산업을 지원하기 위해 560만 달러의 대출을 발표했습니다. 이는 이 지역의 시장 성장을 주도하고 있습니다.

생세포 캡슐화 시장 - 경쟁 상황

생세포 캡슐화 시장의 주요 기업들은 기술 발표, 인수, 연구개발 노력을 주요 사업 전략으로 삼고 있습니다. 주요 참여업체로는 BIO INX, Isogen, Sphere Fluidics Ltd., ViaCyte, Inc.(Dolomite Microfluidics), AUSTRIANOVA, Living Cell Technologies Ltd., Sigilon Therapeutics, Inc., Merck KGaA, Diatranz Otsuka Ltd. 등이 있습니다.

목차

제1장 생세포 캡슐화 시장 개요

• 조사 범위
• 시장 추정 연수

제2장 주요 요약

• 시장 내역
• 경쟁 인사이트

제3장 생세포 캡슐화 주요 시장 동향

• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회
• 향후 시장 동향

제4장 생세포 캡슐화 산업 조사

• PEST 분석
• Porter's Five Forces 분석
• 성장 전망 매핑
• 규제 체계 분석

제5장 생세포 캡슐화 시장 : COVID-19의 영향 분석

• 신종 코로나바이러스 감염증 이전의 영향 분석
• 신종 코로나바이러스 감염증 후의 영향 분석

제6장 생세포 캡슐화 시장 상황

• 생세포 캡슐화 시장 점유율 분석, 2022년
• 주요 제조업체별 내역 데이터
  • 기존 기업 분석
  • 신흥 기업 분석

제7장 생세포 캡슐화 시장 - 폴리머 유형별

• 개요
  • 부문 점유율 분석(폴리머 유형별)
  • 천연 폴리머
  • 합성 폴리머

제8장 생세포 캡슐화 시장 - 방법별

• 개요
  • 부문 점유율 분석(방법별)
  • 마이크로캡슐화
  • 매크로캡슐화
  • 나노캡슐화

제9장 생세포 캡슐화 시장 - 용도별

• 개요
  • 용도별 부문 점유율 분석
  • 약물전달
  • 재생의료
  • 세포 이식
  • 기타

제10장 생세포 캡슐화 시장 - 지역별

• 서론
• 북미
  • 개요
  • 북미의 주요 제조업체
  • 미국
  • 캐나다
• 유럽
  • 개요
  • 유럽의 주요 제조업체
  • 독일
  • 이탈리아
  • 영국
  • 프랑스
  • 러시아
  • 네덜란드
  • 스웨덴
  • 폴란드
  • 기타
• 아시아태평양
  • 개요
  • 아시아태평양의 주요 제조업체
  • 인도
  • 중국
  • 일본
  • 한국
  • 호주
  • 태국
  • 인도네시아
  • 필리핀
  • 기타
• 라틴아메리카
  • 개요
  • 라틴아메리카의 주요 제조업체
  • 브라질
  • 멕시코
  • 아르헨티나
  • 콜롬비아
  • 기타
• 중동 및 아프리카
  • 개요
  • 중동 및 아프리카의 주요 제조업체
  • 사우디아라비아
  • 아랍에미리트
  • 이스라엘
  • 터키
  • 알제리
  • 이집트
  • 기타

제11장 주요 벤더 분석 - 생세포 캡슐화 산업

• 경쟁 대시보드
• 기업 개요
  • BIO INX
  • Isogen
  • Sphere Fluidics Ltd.
  • ViaCyte, Inc.
  • Blacktrace Holdings Ltd.(Dolomite Microfluidics)
  • AUSTRIANOVA
  • Living Cell Technologies Ltd.
  • Sigilon Therapeutics, Inc.
  • Merck KGaA
  • Diatranz Otsuka Ltd.

제12장 애널리스트의 전방위 전망

ksm

영문 목차

영문목차

REPORT HIGHLIGHT

Live Cell Encapsulation Market size was valued at USD 230.8 Million in 2022, expanding at a CAGR of 3.9% from 2023 to 2030.

Using live cell encapsulation, many diseases can be treated. The live cells are enclosed in safe, biocompatible capsules using live cell encapsulation technology. The capsules are open to the blood and nutrients, which feed and sustain the living cells inside. The capsules shield the living cells from the body's immune system destroying them. Within the patient's body, the encapsulated cells are slowly discharged. Furthermore, these cells may be employed to undertake in-vivo research without harming the host DNA.

Live Cell Encapsulation Market- Market Dynamics:

• Technological advancements and novel product launch drives the market growth.

• Key companies' new product launches and technological developments are expected to provide attractive market prospects. For instance, Hydrobio INX N400, the first commercially available bioresin that combines live cell encapsulation with high-resolution biofabrication, was presented by BIO INX in November 2022. Similar to this, ViaCyte, Inc. created two ground-breaking regenerative medicine technology platforms. Various human ailments and diseases that may be treated by replacing damaged or missing cells are addressed by the Encaptra system for cell encapsulation & implantation and stem cell-derived cell replacement treatments. Thus, this is expected to drive market growth during the forecast period.

Live Cell Encapsulation Market- Key Insights:

• As per the analysis shared by our research analyst, the global Live Cell Encapsulation market is estimated to grow annually at a CAGR of around 3.9% over the forecast period (2023-2030)

• The Live Cell Encapsulation industry is projected to grow at a significant rate owing to the growing demand for food testing to ensure the quality

• Based on industry scope, the clinical diagnostics segment is expected to dominate the market during the forecast period

• Based on the technology, the cell culture segment is expected to hold a significant market share over the forecast period

• Based on region, North America is expected to dominate the market during the forecast period

Live Cell Encapsulation Market- Segmentation Analysis:

• The Global Live Cell Encapsulation Market is segmented based on polymer type, method, application, and Region.

• Based on polymer type, the global Live Cell Encapsulation market is segmented into natural and synthetic. The natural segment is expected to dominate the market during the forecast period. The most popular alternative for encapsulation is natural polymers. Large-molecular-weight macromolecules known as "natural polymers" are those that are sourced from nature and are preferred because they are biodegradable, non-toxic, biocompatible, renewable, and adaptable to changes. Since they have a natural origin, such as bacteria, animals, and plants, they can interact with cells and tissues by displaying characteristics that the body recognizes and as a consequence does not perceive them as foreign objects. To transport and distribute hydrophobic or hydrophilic active components, which may be in solid, liquid, or gaseous phases, to the needed places, natural polymers, such as lipids, proteins, and polysaccharides have been used as encapsulation. Thereby, driving the market growth over the forecast period.

Live Cell Encapsulation Market- Geographical Insights:

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period. The market's expansion can be attributed to several factors, including the existence of major players, rising healthcare spending per person, increased funding and investment in research and development programs in the US and Canada, and well-established healthcare infrastructure. According to a report from the Pharmaceutical Research and Manufacturers of America (PhRMA) released in September 2021, biopharmaceutical companies invested more than $1 trillion in research and development up until that point. PhRMA member companies invested about USD 91 billion in that same period. In addition, the Government of Alberta announced in December 2021 financing of USD 5.6 million to support Alberta's life sciences and pharmaceutical industry in Canada. Thereby, driving the market growth in the region.

Live Cell Encapsulation Market- Competitive Landscape:

The Live Cell Encapsulation Market's top players use technology launches, acquisitions, and R&D efforts as their primary business strategies. The key players operating in the market are BIO INX, Isogen, Sphere Fluidics Ltd., ViaCyte, Inc., Blacktrace Holdings Ltd. (Dolomite Microfluidics), AUSTRIANOVA, Living Cell Technologies Ltd., Sigilon Therapeutics, Inc., Merck KGaA and Diatranz Otsuka Ltd.

Recent Developments:

In March 2022, for its clinical trial product candidate, CypCaps, PharmaCyte Biotech, Inc. announced completing a 24-month product stability study mandated by the United States Food and Drug Administration (FDA). At this point, CypCaps has proven to have a shelf life of at least 24 months when kept at -80 degrees Celsius, making it significant.

Key features of the study:

• This proposed research study on Live Cell Encapsulation market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year

• The report provides the client the latest up-to-date and trending insights about the Live Cell Encapsulation market.

• The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Live Cell Encapsulation market

• The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Live Cell Encapsulation market

• Impact of COVID-19 on Live Cell Encapsulation market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Live Cell Encapsulation market post-COVID will also be covered.

• In order to give the users of this report a comprehensive view on the Live Cell Encapsulation market, we have also included competitive landscape and key innovator analysis for the Live Cell Encapsulation market.

• The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

• The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Live Cell Encapsulation market.

• In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

• The global Live Cell Encapsulation market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIVE CELL ENCAPSULATION MARKET KEY PLAYERS

• BIO INX
• Isogen
• Sphere Fluidics Ltd.
• ViaCyte, Inc.
• Blacktrace Holdings Ltd. (Dolomite Microfluidics)
• AUSTRIANOVA
• Living Cell Technologies Ltd.
• Sigilon Therapeutics, Inc.
• Merck KGaA
• Diatranz Otsuka Ltd.

GLOBAL LIVE CELL ENCAPSULATION MARKET, BY POLYMER TYPE

• Natural Polymers
• Synthetic Polymers

GLOBAL LIVE CELL ENCAPSULATION MARKET, BY METHOD

• Microencapsulation
• Macroencapsulation
• Nanoencapsulation

GLOBAL LIVE CELL ENCAPSULATION MARKET, BY APPLICATION

• Drug Delivery
• Regenerative Medicine
• Cell Transplantation
• Others

GLOBAL LIVE CELL ENCAPSULATION MARKET, BY REGION

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Live Cell Encapsulation Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Live Cell Encapsulation Market Snippet by Polymer Type
  • 2.1.2. Live Cell Encapsulation Market Snippet by Method
  • 2.1.3. Live Cell Encapsulation Market Snippet by Application
  • 2.1.4. Live Cell Encapsulation Market Snippet by Country
  • 2.1.5. Live Cell Encapsulation Market Snippet by Region
• 2.2. Competitive Insights

3. Live Cell Encapsulation Key Market Trends

• 3.1. Live Cell Encapsulation Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Live Cell Encapsulation Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Live Cell Encapsulation Market Opportunities
• 3.4. Live Cell Encapsulation Market Future Trends

4. Live Cell Encapsulation Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Live Cell Encapsulation Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Live Cell Encapsulation Market Landscape

• 6.1. Live Cell Encapsulation Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Live Cell Encapsulation Market - By Polymer Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Polymer Type, 2022 & 2030 (%)
  • 7.1.2. Natural Polymers
  • 7.1.3. Synthetic Polymers

8. Live Cell Encapsulation Market - By Method

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Method, 2022 & 2030 (%)
  • 8.1.2. Microencapsulation
  • 8.1.3. Macroencapsulation
  • 8.1.4. Nanoencapsulation

9. Live Cell Encapsulation Market - By Application

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
  • 9.1.2. Drug Delivery
  • 9.1.3. Regenerative Medicine
  • 9.1.4. Cell Transplantation
  • 9.1.5. Others

10. Live Cell Encapsulation Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Live Cell Encapsulation Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Live Cell Encapsulation Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Live Cell Encapsulation Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Live Cell Encapsulation Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Live Cell Encapsulation Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Polymer Type, 2018 - 2030 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Method, 2018 - 2030 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Live Cell Encapsulation Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. BIO INX
  • 11.2.2. Isogen
  • 11.2.3. Sphere Fluidics Ltd.
  • 11.2.4. ViaCyte, Inc.
  • 11.2.5. Blacktrace Holdings Ltd. (Dolomite Microfluidics)
  • 11.2.6. AUSTRIANOVA
  • 11.2.7. Living Cell Technologies Ltd.
  • 11.2.8. Sigilon Therapeutics, Inc.
  • 11.2.9. Merck KGaA
  • 11.2.10. Diatranz Otsuka Ltd.

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us

관련자료